These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32503269)

  • 21. A pharmacological comparison of the cloned frog and human mu opioid receptors reveals differences in opioid affinity and function.
    Brasel CM; Sawyer GW; Stevens CW
    Eur J Pharmacol; 2008 Dec; 599(1-3):36-43. PubMed ID: 18930720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G protein signaling-biased mu opioid receptor agonists that produce sustained G protein activation are noncompetitive agonists.
    Stahl EL; Schmid CL; Acevedo-Canabal A; Read C; Grim TW; Kennedy NM; Bannister TD; Bohn LM
    Proc Natl Acad Sci U S A; 2021 Nov; 118(48):. PubMed ID: 34819362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postsynaptic signaling via the [mu]-opioid receptor: responses of dorsal horn neurons to exogenous opioids and noxious stimulation.
    Trafton JA; Abbadie C; Marek K; Basbaum AI
    J Neurosci; 2000 Dec; 20(23):8578-84. PubMed ID: 11102461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphine and endomorphins differentially regulate micro-opioid receptor mRNA in SHSY-5Y human neuroblastoma cells.
    Yu X; Mao X; Blake AD; Li WX; Chang SL
    J Pharmacol Exp Ther; 2003 Aug; 306(2):447-54. PubMed ID: 12754318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hsp90β positively regulates μ-opioid receptor function.
    Zhang Y; Zhou P; Wang Z; Chen M; Fu F; Su R
    Life Sci; 2020 Jul; 252():117676. PubMed ID: 32304763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct pharmacological properties of morphine metabolites at G(i)-protein and β-arrestin signaling pathways activated by the human μ-opioid receptor.
    Frölich N; Dees C; Paetz C; Ren X; Lohse MJ; Nikolaev VO; Zenk MH
    Biochem Pharmacol; 2011 May; 81(10):1248-54. PubMed ID: 21396918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
    Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Biased View of
    Conibear AE; Kelly E
    Mol Pharmacol; 2019 Nov; 96(5):542-549. PubMed ID: 31175184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area.
    Moreno E; Quiroz C; Rea W; Cai NS; Mallol J; Cortés A; Lluís C; Canela EI; Casadó V; Ferré S
    J Neurosci; 2017 Feb; 37(5):1176-1186. PubMed ID: 28007761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biased Opioid Antagonists as Modulators of Opioid Dependence: Opportunities to Improve Pain Therapy and Opioid Use Management.
    Sadee W; Oberdick J; Wang Z
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32932935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signaling diversity of mu- and delta- opioid receptor ligands: Re-evaluating the benefits of β-arrestin/G protein signaling bias.
    Pineyro G; Nagi K
    Cell Signal; 2021 Apr; 80():109906. PubMed ID: 33383156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct differences between morphine- and [D-Ala2,N-MePhe4,Gly-ol5]-enkephalin-mu-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation.
    Chakrabarti S; Law PY; Loh HH
    J Neurochem; 1998 Jul; 71(1):231-9. PubMed ID: 9648870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heteromerization of μ-opioid receptor and cholecystokinin B receptor through the third transmembrane domain of the μ-opioid receptor contributes to the anti-opioid effects of cholecystokinin octapeptide.
    Yang Y; Li Q; He QH; Han JS; Su L; Wan Y
    Exp Mol Med; 2018 May; 50(5):1-16. PubMed ID: 29780163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential Regulation of 6- and 7-Transmembrane Helix Variants of μ-Opioid Receptor in Response to Morphine Stimulation.
    Convertino M; Samoshkin A; Viet CT; Gauthier J; Li Fraine SP; Sharif-Naeini R; Schmidt BL; Maixner W; Diatchenko L; Dokholyan NV
    PLoS One; 2015; 10(11):e0142826. PubMed ID: 26554831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct association of Mu-opioid and NMDA glutamate receptors supports their cross-regulation: molecular implications for opioid tolerance.
    Garzón J; Rodríguez-Muñoz M; Sánchez-Blázquez P
    Curr Drug Abuse Rev; 2012 Sep; 5(3):199-226. PubMed ID: 22920535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness for the combination of G-protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance.
    Mori T; Kuzumaki N; Arima T; Narita M; Tateishi R; Kondo T; Hamada Y; Kuwata H; Kawata M; Yamazaki M; Sugita K; Matsuzawa A; Baba K; Yamauchi T; Higashiyama K; Nonaka M; Miyano K; Uezono Y; Narita M
    Mol Pain; 2017; 13():1744806917740030. PubMed ID: 29056067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The G-protein biased kappa opioid agonists, triazole 1.1 and nalfurafine, produce non-uniform behavioral effects in male rhesus monkeys.
    Huskinson SL; Platt DM; Zamarripa CA; Dunaway K; Brasfield M; Prisinzano TE; Blough BE; Freeman KB
    Pharmacol Biochem Behav; 2022 Jun; 217():173394. PubMed ID: 35513117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic analysis of factors influencing observations of biased agonism at the mu-opioid receptor.
    Thompson GL; Lane JR; Coudrat T; Sexton PM; Christopoulos A; Canals M
    Biochem Pharmacol; 2016 Aug; 113():70-87. PubMed ID: 27286929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
    Liu JG; Prather PL
    Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DAMGO-induced μ opioid receptor internalization and recycling restore morphine sensitivity in tolerant rat.
    Ma X; Chen R; Huang M; Wang W; Luo L; Kim DK; Jiang W; Xu T
    Eur J Pharmacol; 2020 Jul; 878():173118. PubMed ID: 32320702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.